Msd Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 13.20 Cr
as on 15-06-2024
- Company Age 20 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 12.31%
(FY 2023)
- Profit 24.15%
(FY 2023)
- Ebitda -9.05%
(FY 2023)
- Net Worth 33.57%
(FY 2023)
- Total Assets 18.47%
(FY 2023)
About Msd Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 13.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Msd Pharmaceuticals Private Limited India is Satinder Kaur as COMPANY SECRETARY. Chand Berry, Rehan Abbas, and Yashodhara Ghorpade serve as directors at the Company.
- CIN/LLPIN
U24230DL2004PTC164459
- Company No.
164459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2004
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Msd Pharmaceuticals Private Limited offer?
Msd Pharmaceuticals Private Limited offers a wide range of products and services, including Cranes, Forklift & Lifting Machines, Crane Spare Parts, Freezers, Refrigerators & Chillers, Domestic Refrigerator, Drum Handling Equipment, Office Chairs, Executive Chairs, Office Furniture, High Back Office Chair, Media Player.
Who are the key members and board of directors at Msd Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satinder Kaur | Company Secretary | 07-Jul-2021 | Current |
Rehan Abbas  | Managing Director | 07-May-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chand Berry  | Whole-Time Director | 12-Jan-2021 | Current |
| Yashodhara Ghorpade | Whole-Time Director | 06-Sep-2023 | Current |
Financial Performance and Corporate Structure Insights of Msd Pharmaceuticals.
Msd Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.31% increase. The company also saw a substantial improvement in profitability, with a 24.15% increase in profit. The company's net worth Soared by an impressive increase of 33.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Msd Pharmaceuticals?
In 2023, Msd Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Msd Pharmaceuticals?
Msd Pharmaceuticals has a workforce of 1146 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Msd Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msd Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
